RRM Academy Synopsis
Metformin eases insulin needs without lowering serious newborn risk
This trial gave 502 pregnant women with type 2 diabetes, all on insulin, either metformin or a dummy pill. Adding metformin did not lower the rate of serious newborn problems. Mothers on metformin needed less insulin and had fewer C-sections.
Key Findings
- A composite of serious newborn complications happened in 94 of 233 babies (40.3%) in the metformin group and 95 of 240 (39.6%) on placebo (relative risk 1.02, 95% CI 0.83-1.26).
- Fewer women taking metformin had a cesarean birth: 53.4% versus 62.7% on placebo (relative risk 0.85, 95% CI 0.73-0.99).
- Babies exposed to metformin weighed about 218 grams less on average and were less likely to be born very large, above the 97th percentile (8.6% vs 14.8%, RR 0.58, 95% CI 0.34-0.97).
- More babies in the metformin group were born small for their gestational age: 13.0% versus 6.6% on placebo.
- Women taking metformin reached better blood sugar control and needed noticeably less insulin than women on placebo alone.
Interpretation
This was a large, double-masked, placebo-controlled trial across 29 centers in Canada and Australia. The trial's design makes its main finding trustworthy: adding metformin did not reduce serious newborn complications in women with type 2 diabetes who already needed insulin. The trial also found real trade-offs. Metformin lowered the chance of a very large baby but raised the chance of a small one, and why that shift happens is still unknown. The trial cannot say whether metformin helps or harms women who do not need insulin. The trial also did not follow the babies past birth, so it cannot show whether being smaller affects a child later in life.
RRM Context
Some clinicians use metformin for insulin resistance before a pregnancy starts. So this trial matters: it shows how the drug acts once pregnancy has begun. The trial found effects in two directions: fewer very large babies, but more small babies. That is a reason restorative reproductive medicine, with its cause-based care, follows a couple through conception and continues into the pregnancy itself, past a positive test.
Abstract not indexed.